Wogonin induces cross-regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells

Journal of Cellular Biochemistry

Volumn 113, Issue 11, 2012, Pages 3476-3485

  Chow, Shu Er ^a   Chen, Yu Wen ^a   Liang, Chi Ang ^a   Huang, Yao Kuan ^a   Wang, Jong Shyan ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

AKT; APOPTOSIS; AUTOPHAGY; NPC; WOGONIN

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; WOGONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL MATURATION; CELL SURVIVAL; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; NASOPHARYNX CANCER; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENINE; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; DRUGS, CHINESE HERBAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVANONES; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROLIDES; NASOPHARYNGEAL NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RAF KINASES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84866503294     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24224     Document Type: Article

References (27)

1. Baumann S, Fas SC, Giaisi M, Müller WW, Merling A, Gülow K, Edler L, Krammer PH, Li-Weber M,. 2008. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis. Blood 111: 2354-2363.
2. Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, Mrabti H, Boussen H, Errihani H,. 2011. Treatment for metastatic nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 128: 79-85.
3. Cagnol S, Chambard JC,. 2010. ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence. FEBS J 277: 2-21.
4. Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW, Millward MJ, Hong RL, Whang-Peng J, Ma BB, To KF, Mueser M, Amellal N, Lin X, Chang AY,. 2005. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 23: 3568-3576.
5. Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone P, Malaponte G, Mazzarino MC, Nicoletti F, Libra M, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Milella M, Tafuri A, Bonati A, Evangelisti C, Cocco L, Martelli AM, McCubrey JA,. 2011. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: Rationale and importance to inhibiting these pathways in human health. Oncotarget 2: 135-164.
6. Chen N, Karantza V,. 2011. Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11: 157-168.
7. Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV,. 2005. The Akt//PKB pathway: Molecular target for cancer drug discovery. Oncogene 24: 7482-7492.
8. Chow SE, Chang YL, Chuang SF, Wang JS,. 2011. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and δNp63. Cancer Chemoth Pharm 68: 835-845.
9. Degtyarev M, De Mazière A, Orr C, Lin J, Lee BB, Tien JY, Prior WW, van Dijk S, Wu H, Gray DC, Davis DP, Stern HM, Murray LJ, Hoeflich KP, Klumperman J, Friedman LS, Lin K,. 2008. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol 183: 101-116.
10. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A,. 2009. Life and death partners: Apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16: 966-975.
11. Fan QW, Knight ZA, Goldenberg DD, Yu W, Mostov KE, Stokoe D, Shokat KM, Weiss WA,. 2006. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 9: 341-349.
12. Hay N,. 2005. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-183.
13. Hippert MM, O'Toole PS, Thorburn A,. 2006. Autophagy in cancer: Good, bad, or both ? Cancer Res 66: 9349-9351.
14. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM,. 1990. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 62: 713-724.
15. Liu B, Cheng Y, Liu Q, Bao Jk, Yang JM,. 2010. Autophagic pathways as new targets for cancer drug development. Acta Pharmacol Sin 31: 1154-1164.
16. McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M,. 2006. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzym Regul 46: 249-279.
17. Meijer AJ, Codogno P,. 2004. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 36: 2445-2462.
18. Nicholson KM, Anderson NG,. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395.
19. Palmgren MG,. 1991. Acridine orange as a probe for measuring pH gradients across membranes: Mechanism and limitations. Anal Biochem 192: 316-321.
20. Schmelzle T, Hall MN,. 2000. TOR, a central controller of cell growth. Cell 103: 253-262.
21. Shinojima N, Yokoyama T, Kondo Y, Kondo S,. 2007. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3: 635-637.
22. Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E,. 2005. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1: 84-91.
23. Vucicevic L, Misirkic M, Kristina J, Vilimanovich U, Sudar E, Isenovic E, Prica M, Harhaji-Trajkovic L, Kravic-Stevovic T, Bumbasirevic V, Trajkovic V,. 2011. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway. Autophagy 7: 40-50.
24. Wang M, Tan W, Zhou J, Leow J, Go M, Lee HS, Casey PJ,. 2008. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells. J Biochem Biol 283: 18678-18684.
25. White E, DiPaola RS,. 2009. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15: 5308-5316.
26. Wirawan E, Berghe TV, Lippens S, Agostinis P, Vandenabeele P,. 2011. Autophagy: For better or for worse. Cell Res 22: 43-61.
27. Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y,. 1991. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 266: 17707-17712.